Company intelligence / Profile preview

Happy Bob

Ownership: Private
Development stage: Commercial

Overview

Happy Bob is an FDA-approved digital health app that integrates with Dexcom G6 and G7 CGMs to gamify diabetes management. Clinical results show a 10.5% increase in Time in Range (TIR) for children aged 12+ with type 1 diabetes after 28 days of use alongside Dexcom CGM. The app provides real-time feedback, rewards for glucose control, community support features ("Diabuddies"), and a provider dashboard for remote patient monitoring.

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapyDigital therapeutic (app-based)
Industry: Digital Health Medical Devices

Partnerships

Dexcom Inc. – official integration partner for Dexcom G6/G7 CGMs

Beyond the preview

Go deeper on Happy Bob.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Happy Bob.

Explore the full profile